Abstract PD8-02: Trastuzumab deruxtecan (T-DXd) for advanced breast cancer patients (ABC), regardless HER2 status: A phase II study with biomarkers analysis (DAISY)
暂无分享，去创建一个
F. André | M. Lacroix-Triki | T. Petit | X. Durando | V. Diéras | B. Pistilli | F. Dalenc | T. Bachelot | F. Viret | T. Filleron | L. Venat-Bouvet | E. Deluche | J. Jacquin | C. Lévy | C. Jouannaud | A. Lusque | A. Ducoulombier | F. Du | J. Pierga | L. Salabert | M. F. Mosele | Céline Mahier - Aït Oukhatar